Blog
RSS FeedPosted by Michael Wonder on 14 Jun 2018
Effect of cross-over in oncology clinical trials on evidence levels in early benefit assessment in Germany
13 June 2018 - In oncology clinical trials, cross-over is used frequently but may lead to uncertainties regarding treatment effects. ...
Posted by Michael Wonder on 13 Jun 2018
Metastatic breast cancer: highly selective post-hoc analysis rather than complete publication of quality of life data
13 June 2018 - IQWiG employees criticise the publication practice of PALOMA-2 study authors. ...
Posted by Michael Wonder on 13 Jun 2018
Janssen’s Tremfya (guselkumab) receives its first two positive Health Technology Assessments in Europe
13 June 2018 - The United Kingdom’s NICE publishes positive guidance for the first selective interleukin 23 inhibitor to treat moderate ...
Posted by Michael Wonder on 13 Jun 2018
Drug approved for leukaemia treatment
11 June 2018 - A drug that reduces the chances of relapse for people with an aggressive type of leukaemia ...
Posted by Michael Wonder on 13 Jun 2018
Public backs NHS spending increases
13 June 2018 - An “overwhelming majority” of people support increasing spending on health and social care services, indicates a ...
Posted by Michael Wonder on 13 Jun 2018
Digital health to transform Australia’s health system and save lives
13 June 2018 - Australia now has many of the building blocks in place to roll out a digitally enabled ...
Posted by Michael Wonder on 12 Jun 2018
85% of Canadians now have publicly funded access to a potentially life-extending treatment for patients with rare lung disease
12 June 2018 - Patients living in Alberta, Saskatchewan, Manitoba, Ontario and Newfoundland and Labrador are hopeful Uptravi will soon be ...
Posted by Michael Wonder on 12 Jun 2018
SMC approves funding for six new therapies on the NHS
12 June 2018 - The Scottish Medicines Consortium has approved NHS funding for six new therapies, offering patients new options ...
Posted by Michael Wonder on 12 Jun 2018
Who should pay for HTA?
11 June 2018 - Part of the drive for strengthening EU cooperation on health technology assessment is to tackle duplication ...
Posted by Michael Wonder on 12 Jun 2018
The UK National Institute for Health and Care Excellence to undertake a partial review of the Iluvien reimbursement guidance allowing broader availability
11 June 2018 - More patients in England and Wales with chronic DME could benefit from low-dose corticosteroid intravitreal implant that ...
Posted by Michael Wonder on 12 Jun 2018
Cystic fibrosis patient backs campaign to make medicines available on NHS
10 June 2018 - A cystic fibrosis patient is calling for a medicine to be made available on the NHS ...
Posted by Michael Wonder on 12 Jun 2018
Bunbury mother’s fight to get drug that would give her two-year-old son the chance to grow old
10 June 2018 - The mother of two-year-old Connor Barrett just wants her son given the chance to grow old ...
Posted by Michael Wonder on 11 Jun 2018
Here’s the evidence – time to play fair PHARMAC
11 June 2018 - In light of new clinical trial results, Breast Cancer Foundation New Zealand is urging PHARMAC to ...
Posted by Michael Wonder on 11 Jun 2018
SMC - June 2018 decisions
11 June 2018 - The SMC, has today published advice accepting six new medicines for use by NHSScotland. ...
Posted by Michael Wonder on 11 Jun 2018
Rheumatoid arthritis: few indications of the benefits of certain biologics over others
6 June 2018 - Still no long-term studies and little direct comparisons of biologics/first-time also first-line therapy examined. ...